Research output per year
Research output per year
Personal profile
Research interests
As director of the Pulmonary Hypertension Center and co-director of the Hereditary Hemorrhagic Telangiectasia Center, I work heavily with patients that have pulmonary vascular disorders. I am interested in clinical research in pulmonary hypertension and pulmonary arterio-venous malformations. My interests include pharmacotherapy and non-invasive monitoring tools for patients with pulmonary hypertension and imaging of pulmonary arterio-venous malformations.
Clinical interests
Pulmonary hypertension,thromboembolic disease, hereditary hemorrhagic telangiectasias, pulmonary arteriovenous malformations
Fingerprint
Dive into the research topics where Murali Chakinala is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Disease characteristics, treatments, and outcomes of patients with pulmonary arterial hypertension treated with selexipag in real-world settings from the SPHERE registry (SelexiPag: tHe usErs dRug rEgistry)
McLaughlin, V., Farber, H. W., Highland, K. B., Hemnes, A. R., Chakinala, M. M., Chin, K. M., Han, M., Cho, M., Tobore, T., Rahman, M. & Kim, N. H., Feb 2024, In: Journal of Heart and Lung Transplantation. 43, 2, p. 272-283 12 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
IMPAHCT: A randomized phase 2b/3 study of inhaled imatinib for pulmonary arterial hypertension
Gillies, H., Chakinala, M. M., Dake, B. T., Feldman, J. P., Hoeper, M. M., Humbert, M., Jing, Z. C., Langley, J., McLaughlin, V. V., Niven, R. W., Rosenkranz, S., Zhang, X. & Hill, N. S., Jan 2024, In: Pulmonary Circulation. 14, 1, e12352.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
US commercial health plan coverage dynamics in pulmonary arterial hypertension therapies
Rucker, J. A., Beinfeld, M. T., Enright, D. E., Germack, H. D., Panjabi, S., Chakinala, M. M. & Chambers, J. D., Jun 2024, In: Journal of Managed Care and Specialty Pharmacy. 30, 6, p. 541-548 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose study
Gillies, H., Niven, R., Dake, B. T., Chakinala, M. M., Feldman, J. P., Hill, N. S., Hoeper, M. M., Humbert, M., McLaughlin, V. V. & Kankam, M., Mar 1 2023, In: ERJ Open Research. 9, 2, 00433-2022.Research output: Contribution to journal › Article › peer-review
Open Access10 Scopus citations -
Characteristics of patients with pulmonary arterial hypertension from an innovative, comprehensive real-world patient data repository
Farber, H. W., Chakinala, M. M., Cho, M., Frantz, R. P., Frick, A., Lancaster, L., Milligan, S., Oudiz, R., Panjabi, S., Tsang, Y. & Nathan, S. D., Jul 2023, In: Pulmonary Circulation. 13, 3, e12258.Research output: Contribution to journal › Article › peer-review
Open Access